Cargando…

P1282: MOCRAVIMOD IMPROVES OVERALL SURVIVAL IN AML PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

Detalles Bibliográficos
Autores principales: Medinger, Michael, Passweg, Jakob, Bucher, Christoph, Finke, Juergen, Schanz, Urs, Stylianou, Christos, Dertschnig, Simone, Souquières, Malika, Oehen, Stephan, Kueenburg, Elisabeth, Heim, Dominik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430530/
http://dx.doi.org/10.1097/01.HS9.0000972016.06838.fa
_version_ 1785090986229104640
author Medinger, Michael
Passweg, Jakob
Bucher, Christoph
Finke, Juergen
Schanz, Urs
Stylianou, Christos
Dertschnig, Simone
Souquières, Malika
Oehen, Stephan
Kueenburg, Elisabeth
Heim, Dominik
author_facet Medinger, Michael
Passweg, Jakob
Bucher, Christoph
Finke, Juergen
Schanz, Urs
Stylianou, Christos
Dertschnig, Simone
Souquières, Malika
Oehen, Stephan
Kueenburg, Elisabeth
Heim, Dominik
author_sort Medinger, Michael
collection PubMed
description
format Online
Article
Text
id pubmed-10430530
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104305302023-08-17 P1282: MOCRAVIMOD IMPROVES OVERALL SURVIVAL IN AML PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION Medinger, Michael Passweg, Jakob Bucher, Christoph Finke, Juergen Schanz, Urs Stylianou, Christos Dertschnig, Simone Souquières, Malika Oehen, Stephan Kueenburg, Elisabeth Heim, Dominik Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430530/ http://dx.doi.org/10.1097/01.HS9.0000972016.06838.fa Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Medinger, Michael
Passweg, Jakob
Bucher, Christoph
Finke, Juergen
Schanz, Urs
Stylianou, Christos
Dertschnig, Simone
Souquières, Malika
Oehen, Stephan
Kueenburg, Elisabeth
Heim, Dominik
P1282: MOCRAVIMOD IMPROVES OVERALL SURVIVAL IN AML PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
title P1282: MOCRAVIMOD IMPROVES OVERALL SURVIVAL IN AML PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
title_full P1282: MOCRAVIMOD IMPROVES OVERALL SURVIVAL IN AML PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
title_fullStr P1282: MOCRAVIMOD IMPROVES OVERALL SURVIVAL IN AML PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
title_full_unstemmed P1282: MOCRAVIMOD IMPROVES OVERALL SURVIVAL IN AML PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
title_short P1282: MOCRAVIMOD IMPROVES OVERALL SURVIVAL IN AML PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
title_sort p1282: mocravimod improves overall survival in aml patients undergoing allogeneic hematopoietic cell transplantation
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430530/
http://dx.doi.org/10.1097/01.HS9.0000972016.06838.fa
work_keys_str_mv AT medingermichael p1282mocravimodimprovesoverallsurvivalinamlpatientsundergoingallogeneichematopoieticcelltransplantation
AT passwegjakob p1282mocravimodimprovesoverallsurvivalinamlpatientsundergoingallogeneichematopoieticcelltransplantation
AT bucherchristoph p1282mocravimodimprovesoverallsurvivalinamlpatientsundergoingallogeneichematopoieticcelltransplantation
AT finkejuergen p1282mocravimodimprovesoverallsurvivalinamlpatientsundergoingallogeneichematopoieticcelltransplantation
AT schanzurs p1282mocravimodimprovesoverallsurvivalinamlpatientsundergoingallogeneichematopoieticcelltransplantation
AT stylianouchristos p1282mocravimodimprovesoverallsurvivalinamlpatientsundergoingallogeneichematopoieticcelltransplantation
AT dertschnigsimone p1282mocravimodimprovesoverallsurvivalinamlpatientsundergoingallogeneichematopoieticcelltransplantation
AT souquieresmalika p1282mocravimodimprovesoverallsurvivalinamlpatientsundergoingallogeneichematopoieticcelltransplantation
AT oehenstephan p1282mocravimodimprovesoverallsurvivalinamlpatientsundergoingallogeneichematopoieticcelltransplantation
AT kueenburgelisabeth p1282mocravimodimprovesoverallsurvivalinamlpatientsundergoingallogeneichematopoieticcelltransplantation
AT heimdominik p1282mocravimodimprovesoverallsurvivalinamlpatientsundergoingallogeneichematopoieticcelltransplantation